Pharmafile Logo

DDI LLC

DDi is a prominent Technology partner to the Life Sciences industry. DDi has built its solution competency with a unique blend of functional and domain expertise to serve the technology needs of global clients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

 Latest Content from PMHub 

Conducting market research for scientific publication guide

Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in...

Therapy Watch appoints new Associate Director

Research Partnership has appointed Mark Hollis to join the Therapy Watch team as Associate Director. Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA...

Sabera Hyderally appointed Head of MedTech North America

Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.

Full speed ahead: Unlock the full potential of your brand tracking

Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Lucid Group are on the Lookout for World-Shaking Talent

Lucid Group kick-started the week with its second exchange day in 2018, held in their Macclesfield office. With continued growth from new and existing clients, the need to find and...

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

New insights into making behavioural change work

The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. Lifestyle conditions, or noncommunicable...

Fulfilling Dreams, Talent and Ambition – The Lucid Futures Academy

The inaugural class of 2018 graduate from Lucid’s Futures Academy

Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack

Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...